This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Therapeutic Drug Monitoring Markets

Figure 6.1: Panel of Assays Available for the Abbott iSTAT 81

Figure 7.1: Principle of ELISA 126

Figure 7.2: Enzyme Multiplied Immunoassay Technique (EMIT) 127

Figure 7.3: Flow Diagram of High Pressure Liquid Chromatography 129

Figure 8.1: Market Share Ultra-Large Clinical Chemistry Analyzers U.S. 131

Figure 8.2: Market Share Ultra-Large Clinical Chemistry Analyzers Non-U.S. 131

Figure 8.3: Global Sales of Chemical Analyzers from Roche Diagnostics, 2010 136

Figure 9.1: Summary of Strengths, Weaknesses, Opportunities and Threats of

Therapeutic Drug

Test Market 145

Figure 10.1: Roche Diagnostics Sales Volume, 2008-2012 146

Figure 10.2: Roche Diagnostics Core Operating Profit, 2010-2012 147

Figure 10.3: Roche Diagnostics Sales by Global Region, 2012 148

Figure 10.4: Abbott's Two New Companies in 2012 – Diversified Medical Products

and Research-Based Pharmaceuticals 149

Figure 10.5: Abbott Diversified Medical Product Portfolio 150

Figure 10.6: Abbott Laboratories Global Annual Sales, 2008-2012 150

Figure 10.7: Abbott Laboratories Net Earnings, 2010-2012 150

Figure 10.8: Abbott Laboratories Net Sales – Diagnostics Division, 2010-2012 151

Figure 10.9: Siemens Market Share by Geographic Region, 2012 152

Figure 10.10: Thermo Fisher Revenue Generated by Geographic Region, 2011 152

Figure 10.11: Beckman Coulter Revenue by Geographic Region, 2010 154

Figure 10.12: Beckman Coulter Revenue by Segment, 2010 155

Figure 10.13: Revenue Generated by OraSure's Oral Fluid Collection Devices,

2010-2011 157

Figure 10.14: Bayer Company Structure – Health Care, Crop Science and Material

Science 160

Figure 10.15: Bayer Global Sales by Geographic Market, 2011 162

Figure 10.16: BioRad Global Net Sales, 2007-2011 164

Figure 10.17: BioRad Geographical Breakdown of Sales, 2011 164

Figure 10.18: Research and Development Expenditure, BioRad 2007-2011 165

Figure App 1.1: Volume of Distribution of Various Therapeutic Drugs 167

Figure App 1.2: Major Pharmacokinetic Processes Affecting Drug Concentration 168

Figure App 1.3: Role of Cytochrome P450 Enzymes in Hepatic Metabolism – Relative

Hepatic Content

of CYP Enzyme 169

9 of 10

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs